Early clinical evidence of efficacy, safety of UCN-01 plus fludarabine phosphate in CLL Dec. 11, 2000
Atrix completes phase III study of 1-month Leuprogel formulation in advanced prostate cancer Dec. 7, 2000
Data presented at AHS meeting support further development of G-3139 in combination regimens Dec. 7, 2000
Tezacitabine, an antimetabolite nucleoside analogue, assessed in hematological malignancies Dec. 7, 2000
Synthetic camptothecin derivative shows potential in AML and other hematological malignancies Dec. 7, 2000
RSS